
Argenx Discontinued Phase 3 Sjögren's Disease Trial
A clinical trial for the treatment of moderate-to-severe Sjögren's disease has been halted for futility.
Live Poll
Do you trust pharmaceutical companies to prioritize patient health outcomes over successful clinical trial results?